systemic%20lupus%20erythematosus%20(pediatric)
SYSTEMIC LUPUS ERYTHEMATOSUS (PEDIATRIC)
Systemic lupus erythematosus is a chronic, multisystem, inflammatory, autoimmune disorder characterized by formation of autoantibodies directed against self-antigens and immune-complex formation.
It can be suspected when ≥2 organ systems are involved.
It is predominantly diagnosed in females of childbearing age, rarely diagnosed before 8 years old.
Clinical presentation varies in different patients and the disease activity varies over time in a single patient. Majority of patients have arthralgia of the hand.

Differential Diagnosis

  • Antiphospholipid antibody syndrome
  • Drug-induced lupus
  • Early rheumatoid arthritis
  • Fibromyalgia w/ positive antinuclear antibody (ANA)
  • Idiopathic thrombocytopenic purpura
  • Scleroderma
  • Sjogren’s syndrome
  • Systemic sclerosis
  • Undifferentiated connective tissue disease
  • Vasculitis
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
04 Apr 2018
Early progressive feeding is feasible and effective in increasing the number of full enteral feeding days in extremely preterm infants, suggests a recent study.
Tristan Manalac, 06 Apr 2018
Receptivity to any tobacco advertising is high among adolescents, and e-cigarette advertising is the most effective, reports a recent US study, which also shows that receptivity to advertising is associated with progression to use.
21 Mar 2018
Dr Elizabeth Carpenter, Principal Scientist of Dairy Goat Co-operative (DGC) in New Zealand, spoke to MIMS about goat milk as a source of protein in childhood nutrition. Below are highlights from the interview.
Pearl Toh, 05 Apr 2018
Adding tiotropium to inhaled corticosteroids (ICS) appeared safe and well tolerated in preschool children with persistent asthmatic symptoms, reveals an exploratory, regulatory trial—suggesting that tiotropium may be a complementary strategy for managing this young population for whom treatment options are scarce.